Your browser doesn't support javascript.
loading
Neutralizing antibodies against adenovirus type 2 in normal and HIV-1-infected subjects: Implications for use of Ad2 vectors in vaccines.
Li, Qianqian; Liu, Qiang; Huang, Weijing; Song, Aijing; Zhao, Chenyan; Wu, Jiajing; Wang, Youchun.
Afiliação
  • Li Q; a Division of HIV/AIDS and Sex-transmitted Virus Vaccines, Key Laboratory of the Ministry of Health for Research on Quality and Standardization of Biotech Products , National Institutes for Food and Drug Control , Beijing , China.
  • Liu Q; a Division of HIV/AIDS and Sex-transmitted Virus Vaccines, Key Laboratory of the Ministry of Health for Research on Quality and Standardization of Biotech Products , National Institutes for Food and Drug Control , Beijing , China.
  • Huang W; a Division of HIV/AIDS and Sex-transmitted Virus Vaccines, Key Laboratory of the Ministry of Health for Research on Quality and Standardization of Biotech Products , National Institutes for Food and Drug Control , Beijing , China.
  • Song A; a Division of HIV/AIDS and Sex-transmitted Virus Vaccines, Key Laboratory of the Ministry of Health for Research on Quality and Standardization of Biotech Products , National Institutes for Food and Drug Control , Beijing , China.
  • Zhao C; a Division of HIV/AIDS and Sex-transmitted Virus Vaccines, Key Laboratory of the Ministry of Health for Research on Quality and Standardization of Biotech Products , National Institutes for Food and Drug Control , Beijing , China.
  • Wu J; a Division of HIV/AIDS and Sex-transmitted Virus Vaccines, Key Laboratory of the Ministry of Health for Research on Quality and Standardization of Biotech Products , National Institutes for Food and Drug Control , Beijing , China.
  • Wang Y; a Division of HIV/AIDS and Sex-transmitted Virus Vaccines, Key Laboratory of the Ministry of Health for Research on Quality and Standardization of Biotech Products , National Institutes for Food and Drug Control , Beijing , China.
Hum Vaccin Immunother ; 13(6): 1-8, 2017 06 03.
Article em En | MEDLINE | ID: mdl-28301274
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Portadores de Fármacos / Vacinas Virais / Infecções por HIV / Adenovírus Humanos / Infecções por Adenoviridae / Anticorpos Neutralizantes / Anticorpos Antivirais Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Adult / Animals / Female / Humans / Male / Middle aged País/Região como assunto: Asia Idioma: En Revista: Hum Vaccin Immunother Ano de publicação: 2017 Tipo de documento: Article País de afiliação: China
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Portadores de Fármacos / Vacinas Virais / Infecções por HIV / Adenovírus Humanos / Infecções por Adenoviridae / Anticorpos Neutralizantes / Anticorpos Antivirais Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Adult / Animals / Female / Humans / Male / Middle aged País/Região como assunto: Asia Idioma: En Revista: Hum Vaccin Immunother Ano de publicação: 2017 Tipo de documento: Article País de afiliação: China